Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | KIF18A | Q8NI77 | 4/20 | 0.44 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | MET | P08581 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | HTR1A | P08908 | 1/20 | 0.42 |
| ▸ | HTR2A | P28223 | 1/20 | 0.42 |
| ▸ | OGA | O60502 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6644382 | 0.90 | ALDH1A1 (0.46) | L3MBTL1ALDH1A1KMT2AMAPTGAA | |
| SCHEMBL6649434 | 0.89 | L3MBTL1 (0.68) | L3MBTL1ALDH1A1KMT2AMAPTNPC1 | |
| SCHEMBL6645164 | 0.87 | ALDH1A1 (0.54) | L3MBTL1ALDH1A1KMT2AMAPTGAA | |
| SCHEMBL6643270 | 0.84 | ALDH1A1 (0.45) | ALDH1A1KMT2AMAPTGAANPC1 | |
| SCHEMBL6647790 | 0.83 | KMT2A (0.51) | L3MBTL1ALDH1A1KMT2AMAPTGAA | |
| SCHEMBL6645448 | 0.81 | L3MBTL1 (0.55) | L3MBTL1ALDH1A1MAPTGAANPC1 | |
| SCHEMBL6644731 | 0.80 | ALDH1A1 (0.45) | L3MBTL1ALDH1A1KMT2AMAPTGAA | |
| SCHEMBL6647632 | 0.79 | HTR2C (0.47) | L3MBTL1ALDH1A1KMT2AMAPTGAA | |
| SCHEMBL6645777 | 0.78 | SCN10A (0.43) | L3MBTL1ALDH1A1KMT2AMAPTGAA | |
| SCHEMBL6829454 | 0.78 | KMT2A (0.64) | L3MBTL1ALDH1A1KMT2AMAPTGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040133008-A1 | Amide compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-07-08 | — | — | US | disclosed |
| WO-2004039795-A2 | AMIDE COMPOUNDS FOR THE TREATMENT OF HYPERLIPIDEMIA | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-05-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040133008-A1 | Amide compounds | APOB, APOL1, LDLR | L3MBTL1 1609/4885ALDH1A1 2174/4885KMT2A 916/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.